Article
The pharmacogenetics of methotrexate
25 Jun 2007
Abstract excerpt
Methotrexate (MTX) is a cornerstone of therapy for rheumatoid arthritis. However, it is not universally effective and up to one-third of patients fail to respond to treatment, either because of inefficacy or adverse events, although at present it is not possible to predict therapy response accurately. Pharmacogenetics is the study of variability in drug response due to heredity. MTX has a complex intracellular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
